Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
3 hedge funds and large institutions have $94K invested in Bio Green Med Solution Inc Preferred Stock in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
4.49% more ownership
Funds ownership: 0% → 4.49% (+4.5%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
3% less capital invested
Capital invested by funds: $97K → $94K (-$3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.93K |
BGMSP Hedge Fund Activity: Q4 2016 in Review
3 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q4 2016, worth a combined $94K — down 3.1% from $97K a quarter earlier.
Fund positioning in BGMSP was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $8.23K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.93K.
- 3 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $94K of Bio Green Med Solution Inc Preferred Stock stock for Q4 2016, down 3.1% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q4 2016 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q4 2016 was UBS Group, an estimated $8.23K added.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q4 2016 was Tower Research Capital (TRC), an estimated $1.93K sold.
Based on aggregated 13F filings for Q4 2016.